Cargando…

Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?

In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical chal...

Descripción completa

Detalles Bibliográficos
Autor principal: Brüssow, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Microbiology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322549/
https://www.ncbi.nlm.nih.gov/pubmed/22493030
http://dx.doi.org/10.1128/mBio.00061-12
_version_ 1782229073914757120
author Brüssow, Harald
author_facet Brüssow, Harald
author_sort Brüssow, Harald
collection PubMed
description In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical challenges that antibiotic resistance in biofilms can represent. In the March 6, 2012 issue of mBio, Colin Hill and his colleagues report on experiments that add to the evidence that Pseudomonas phages are a potential treatment option for these infections.
format Online
Article
Text
id pubmed-3322549
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Society of Microbiology
record_format MEDLINE/PubMed
spelling pubmed-33225492012-04-16 Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? Brüssow, Harald mBio Commentary In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical challenges that antibiotic resistance in biofilms can represent. In the March 6, 2012 issue of mBio, Colin Hill and his colleagues report on experiments that add to the evidence that Pseudomonas phages are a potential treatment option for these infections. American Society of Microbiology 2012-04-03 /pmc/articles/PMC3322549/ /pubmed/22493030 http://dx.doi.org/10.1128/mBio.00061-12 Text en Copyright © 2012 Brüssow http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/) , which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Commentary
Brüssow, Harald
Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title_full Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title_fullStr Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title_full_unstemmed Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title_short Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
title_sort pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322549/
https://www.ncbi.nlm.nih.gov/pubmed/22493030
http://dx.doi.org/10.1128/mBio.00061-12
work_keys_str_mv AT brussowharald pseudomonasbiofilmscysticfibrosisandphageasilverlining